Online citations, reference lists, and bibliographies.
← Back to Search

Repeat Botulinum Toxin‐A Injections In The Upper Limb Of Children With Hemiplegia: A Randomized Controlled Trial

Christine A Olesch, S. Greaves, C. Imms, S. Reid, H. K. Graham
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Aim To test the effectiveness of repeat botulinum toxin A (BoNT‐A) injections in the affected arm of 22 children with hemiplegic cerebral palsy (19 males, three females), aged 1 year 10 months to 4 years 10 months (mean 3y 8mo, SD 9mo) in a randomized controlled trial.
This paper references
ICF Children and Youth Version
World Health Organisation. International Classification Functioning (2009)
COPM: Canadian Occupational Performance Measure
M Law (2005)
10.1097/00001577-199801020-00013
Botulinum Toxin A in the Hemiplegic Upper Limb: A Double‐blind Trial
L. Arens (1997)
10.1053/APMR.2003.50001
Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
E. Hurvitz (2003)
10.1111/j.1468-1331.1999.tb00031.x
Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
R. Boyd (1999)
10.1542/peds.2006-2425
Upper-Limb Botulinum Toxin A Injection and Occupational Therapy in Children With Hemiplegic Cerebral Palsy Identified From a Population Register: A Single-Blind, Randomized, Controlled Trial
R. Russo (2007)
10.1300/J006v24n01_04
Activity-Focused Motor Interventions for Children with Neurological Conditions
J. Valvano (2004)
10.1177/0269215506073494
Goal-directed training: linking theories of treatment to clinical practice for improved functional activities in daily life
M. Mastos (2007)
10.1111/j.1469-8749.2007.00331.x
A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity
Anne Kawamura (2007)
10.1080/11038120310004529
Development of the Assisting Hand Assessment: A Rasch-built Measure intended for Children with Unilateral Upper Limb Impairments
L. Krumlinde-Sundholm (2003)
10.1097/00004397-199303340-00016
Pharmacology of Botulinum Toxin
R. Gonnering (1993)
10.1016/J.APMR.2003.05.008
Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial.
M. Wallen (2004)
10.1080/09638280600929201
Adapting the Canadian Occupational Performance Measure for use in a paediatric clinical trial
A. Cusick (2007)
10.1016/S0140-6736(03)15351-2
Sonography-guided injection of botulinum toxin in children with cerebral palsy
S. Berweck (2004)
10.1017/S0012162206000387
Low‐dose/high‐concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy
K. Lowe (2006)
10.1136/bmj.322.7280.226
Sifting the evidence—what's wrong with significance tests?
J. Sterne (2001)
10.1111/j.1469-8749.2007.00823.x
Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy
K. Lowe (2007)
Characterizing functional limitations in children using the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY)
J. L. Mory (2010)
10.1177/0269215506070703
The reproducibility and validity of the Canadian Occupational Performance Measure in parents of children with disabilities
Gijs J Q Verkerk (2006)
10.5014/AJOT.58.4.389
Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for occupational therapists.
B. Hoare (2004)
QUEST: Quality of Upper Extremity Skills Test. Hamilton, ON, Canada: McMaster University Neurodevelopmental
C DeMatteo (1992)
10.1136/ADC.83.3.279A
Cerebral palsies: epidemiology and causal pathways
A. Johnson (2000)
10.1017/S0012162206001162
The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability.
A. Eliasson (2006)
10.1111/j.1469-8749.2004.tb00481.x
Intraobserver reliability of the modified Tardieu scale in the upper limb of children with hemiplegia
A. Mackey (2004)
10.1111/j.1440-1754.2005.00687.x
Cerebral palsy in Victoria: Motor types, topography and gross motor function
Jason J Howard (2005)
10.1046/j.1468-1331.2001.00047.x
Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome
D. Fehlings (2001)
10.1111/j.1469-8749.1997.tb07408.x
Botulinum toxin A in the hemiplegia upper limb: a double‐blind trial
I. S. Corry (1997)
10.1111/j.1469-8749.2005.tb01173.x
Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy
L. Speth (2005)
10.1177/000841740407100406
The Canadian Occupational Performance Measure: A Research and Clinical Literature Review
A. Carswell (2004)
10.1097/01.bpo.0000150819.72608.86
Accuracy of Intramuscular Injection of Botulinum Toxin A in Juvenile Cerebral Palsy: A Comparison Between Manual Needle Placement and Placement Guided by Electrical Stimulation
Terence Y P Chin (2005)
10.1007/978-3-319-67858-0_21
Management of the upper limb in cerebral palsy
Terence Y P Chin (2005)
10.1016/J.APMR.2006.10.017
Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
M. Wallen (2007)
International Classification of Functioning , Disability and Health ( ICF ) : ICF Children and Youth Version
K Lowe



This paper is referenced by
10.2340/16501977-0886
Linking cerebral palsy upper limb measures to the International Classification of Functioning, Disability and Health.
B. Hoare (2011)
10.1016/j.ejpn.2009.09.005
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.
F. Heinen (2010)
10.1542/peds.2013-0675
Efficacy of Upper Limb Therapies for Unilateral Cerebral Palsy: A Meta-analysis
L. Sakzewski (2014)
10.1016/j.rehab.2009.10.005
Kienböck's disease and cerebral palsy case report.
Philippe Gallien (2010)
10.1097/WCO.0b013e32833ff4c4
Evidence-based therapies for upper extremity dysfunction.
J. Liepert (2010)
10.2182/cjot.2012.79.1.2
Canadian Occupational Performance Measure: Impact of Blinded Parent-Proxy Ratings on Outcome
M. Wallen (2012)
10.1016/B978-0-7020-5099-2.00013-3
Very early upper limb interventions for infants with asymmetric brain lesions
R. Boyd (2013)
10.5935/0104-7795.20120019
Cerebral palsy - upper limbs: rehabilitation
V. Arakaki (2012)
10.1155/2012/802893
Therapeutic Use of Botulinum Toxin in Neurorehabilitation
D. Intiso (2012)
10.3109/01942638.2013.799627
Change in Parent-Identified Goals in Young Children with Cerebral Palsy Receiving a Context-Focused Intervention: Associations with Child, Goal and Intervention Factors
N. Pollock (2014)
Repeat upper limb botulinum toxin A injections: a reflection of clinical practice
B. Oddson (2010)
10.1177/0883073815596609
Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement
B. Karaca (2016)
10.1016/j.spen.2010.10.009
Pharmacologic treatment of spasticity in children.
A. Tilton (2010)
10.1177/0883073814533196
Rationale for Using Botulinum Toxin A as an Adjunct to Upper Limb Rehabilitation in Children With Cerebral Palsy
B. Hoare (2014)
10.3390/toxins5030524
Safety of Botulinum Toxin A in Children and Adolescents with Cerebral Palsy in a Pragmatic Setting
A. Papavasiliou (2013)
10.1186/1471-2377-12-21
Valid and reliable instruments for arm-hand assessment at ICF activity level in persons with hemiplegia: a systematic review
R. Lemmens (2012)
10.1111/j.1469-8749.2009.03408.x
Repeat upper limb botulinum toxin A injections: a reflection of clinical practice
L. Sakzewski (2010)
10.1590/1809-2950/18018026042019
Comprimento de isquiotibiais, função motora grossa e marcha em crianças e adolescentes com paralisia cerebral
P. S. Chagas (2019)
10.3109/09638288.2011.591882
Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review
C. Phadke (2012)
10.1111/dmcn.13653
Economic evaluation and cost of interventions for cerebral palsy: a systematic review
S. Shih (2018)
10.1016/J.MOTCER.2010.07.001
Actualités et perspectives dans la prise en charge de l’hémiplégie cérébrale infantile en médecine physique et de réadaptation
Céline Bonhomme (2010)
10.1155/2012/678963
Medical Applications of Clostridia and Clostridial Toxins
M. Hale (2012)
10.1016/j.jcot.2020.01.002
Effect of botulinum toxin type-A in spasticity and functional outcome of upper limbs in cerebral palsy.
S. Yadav (2020)
10.1109/NER.2019.8717098
Variations of Tendon Tap Force Threshold needed to Evoke Surface Electromyogram Responses after Botulinum Toxin Injection in Chronic Stroke Survivors*
Babak Afsharipour (2019)
10.1007/978-3-319-41142-2_41
Upper Limb Problems in Children with Cerebral Palsy
J. Baxter (2017)
10.3233/NRE-2010-0596
Spasticity: revisiting the role and the individual value of several pharmacological treatments.
E. Lapeyre (2010)
Effects of botulinum toxin A injections and bimanual task-oriented therapy on hand functions and bimanual activities in unilateral Cerebral Palsy
L Speth (2015)
10.1186/1471-2431-12-120
Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial
Megan Thorley (2012)
10.7499/J.ISSN.1008-8830.2016.02.006
[Effect of botulinum toxin A injection in the treatment of gastrocnemius spasticity in children aged 9-36 months with cerebral palsy: a prospective study].
D. Zhu (2016)
10.1111/dmcn.13135
Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review
Aysu Kahraman (2016)
10.3389/fneur.2014.00281
Early Intervention to Improve Hand Function in Hemiplegic Cerebral Palsy
A. Basu (2015)
10.3390/toxins5010060
Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic Review
C. Druschel (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar